Piers Blombery Selected Research

Piers Blombery Research Topics

Disease

17	Neoplasms (Cancer) 01/2023 - 10/2011
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2023 - 01/2019
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 01/2019
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2018
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 05/2016
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 04/2021
3	Lymphoma (Lymphomas) 01/2023 - 01/2018
3	Multiple Myeloma 06/2022 - 10/2011
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021 - 02/2011
3	Disease Progression 01/2020 - 01/2019
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019 - 01/2016
3	Thrombotic Thrombocytopenic Purpura 06/2018 - 01/2014
3	Infections 06/2018 - 10/2011
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2023 - 01/2019
2	VEXAS syndrome 01/2023 - 11/2022
2	Residual Neoplasm 01/2022 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2020
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 10/2021
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2018 - 11/2009
2	Malignant Hypertension 06/2018 - 01/2018
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2017 - 11/2009
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2024
1	Erdheim-Chester Disease 01/2023
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Cytopenia 01/2023
1	Autosomal Recessive 3 Severe Congenital Neutropenia 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2022
1	Hematologic Neoplasms (Hematological Malignancy) 06/2022
1	Bone Marrow Failure Disorders 01/2022
1	Cytomegalovirus Infections (Inclusion Disease) 10/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2021
1	Glomerulonephritis 01/2021
1	Paraproteinemias (Monoclonal Gammopathy) 01/2021
1	Chromosome Fragility 06/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019
1	Leukemia 01/2018
1	Stomatitis 08/2014
1	Neutropenia 08/2014
1	Mucositis 08/2014

Drug/Important Bio-Agent (IBA)

14	venetoclaxIBA 01/2023 - 01/2019
4	Rituximab (Mabthera)FDA Link 11/2023 - 02/2011
4	ibrutinibIBA 10/2023 - 01/2019
4	Agammaglobulinaemia Tyrosine KinaseIBA 02/2023 - 10/2021
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
3	Chimeric Antigen ReceptorsIBA 10/2023 - 04/2021
3	thiamine triphosphorate (TTP)IBA 06/2018 - 01/2014
2	LigandsIBA 01/2023 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2021
2	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021 - 11/2018
2	Circulating Tumor DNAIBA 01/2019 - 01/2017
2	Shiga Toxin (Shigella Toxin)IBA 06/2018 - 01/2018
2	romidepsin (FK228)FDA Link 01/2017 - 11/2009
1	OMS 2017IBA 03/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2024
1	avatrombopagIBA 01/2024
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2024
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	ProteomeIBA 01/2023
1	VemurafenibIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	dabrafenibIBA 01/2023
1	Initiator Codon (Start Codon)IBA 01/2023
1	avelumabIBA 01/2023
1	EnzymesIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	tert-butylserineIBA 01/2022
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2022
1	CD19-specific chimeric antigen receptorIBA 10/2021
1	ParaffinIBA 10/2021
1	Formaldehyde (Formol)FDA Link 10/2021
1	Complement System Proteins (Complement)IBA 06/2020
1	Radioisotopes (Radionuclides)IBA 08/2019
1	Peptide Receptors (Peptide Receptor)IBA 08/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	CX 5461IBA 01/2019
1	Ribosomal DNA (rDNA)IBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	RNA Polymerase I (Polymerase I, RNA)IBA 01/2019
1	CopperIBA 05/2016
1	Melphalan (Alkeran)FDA LinkGeneric 08/2014

Therapy/Procedure

16	Therapeutics 01/2023 - 08/2014
7	Drug Therapy (Chemotherapy) 02/2023 - 08/2014
3	Stem Cell Transplantation 11/2023 - 10/2011
3	Breast Implants (Breast Implant) 01/2019 - 01/2016
1	Autologous Transplantation 11/2023
1	Remission Induction 01/2022
1	Immunotherapy 04/2021
1	Brachytherapy 01/2020
1	Prostheses and Implants (Prosthesis) 11/2018
1	Induction Chemotherapy 01/2018
1	Analgesia 08/2014
1	Total Parenteral Nutrition 08/2014